GHRH analogue comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-20. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。
It includes the midbrain, pons, and medulla oblongata and regulates essential functions such as breathing, heart rate, and sleep. Brain ventricles A set of interconnected cavities within the brain that produce and circulate cerebrospinal fluid (CSF). Includes the lateral, third, and fourth ventricles. Brain waves Patterns of electrical activity in the brain, typically detected by electroencephalography (EEG). Brain waves are categorized by frequency, such as alpha, beta, delta, and theta waves. Brain-computer interface (BCI) A technology that enables direct communication between the brain and an external device, often used in research, prosthetics, and communication aids for individuals with disabilities. Bradykinesia Slowness of movement, often a symptom of Parkinson’s disease and other disorders involving the basal ganglia. Broca's area A region in the frontal lobe, typically in the left hemisphere, associated with the production of speech. Damage can result in Broca's aphasia, characterized by impaired speech fluency. Broca's aphasia A language disorder caused by damage to Broca's area, resulting in slow, laborious speech with relatively preserved comprehension. Brodmann areas Regions of the cerebral cortex defined by Korbinian Brodmann based on cytoarchitecture. These areas are still widely used to describe functional brain localization (e.g., Brodmann area 17 = primary visual cortex). Burst firing A pattern of rapid spikes from a neuron followed by a period of quiescence. It plays a role in sensory encoding and signal amplification in various brain circuits.
In May 1972, President Richard M. Nixon and Soviet Premier Leonid Brezhnev negotiated an easing of relations known as détente, creating a temporary "thaw" in the Cold War. The two nations planned a joint mission to dock the last US Apollo craft with a Soyuz, known as the Apollo-Soyuz Test Project (ASTP). To prepare, the US designed a docking module for the Apollo that was compatible with the Soviet docking system, which allowed any of their craft to dock with any other (e.g. Soyuz-to-Soyuz as well as Soyuz-to-Salyut). The module was also necessary as an airlock to allow the men to visit each other's craft, which had incompatible cabin atmospheres. The USSR used the Soyuz 16 mission in December 1974 to test modifications of the Soyuz atmosphere and the docking adapter to prepare for ASTP. The joint mission began when Soyuz 19 was first launched on July 15, 1975, at 12:20 UTC, and the Apollo craft was launched with the docking module six and a half hours later. The two craft rendezvoused and docked on July 17 at 16:19 UTC. The three astronauts conducted joint experiments with the two cosmonauts, and the crew shook hands, exchanged gifts, and visited each other's craft.
White for hydrogen Black for carbon Sky blue for nitrogen Red for oxygen They also built smaller models using plastic balls with the same color schema. In 1965 Koltun patented an improved version of the Corey and Pauling modeling technique. In his patent he mentions the following colors:
In November 1917, after learning of the uprising in Petrograd (now called Saint Petersburg), Moscow's Bolsheviks started an uprising. On 2 November [O.S. 15 November] 1917, after heavy fighting, Soviet power was established in Moscow. Vladimir Lenin, fearing invasion, moved the state's capital back to Moscow on 12 March 1918. The Kremlin once again became the seat of power, the political center of the new state. With the change in societal values imposed by communist ideology, the tradition of preserving cultural heritage was broken. Independent preservation societies, even those that defended only secular landmarks, were disbanded by the end of the 1920s. A new anti-religious campaign, launched in 1929, coincided with the collectivization of peasants; the destruction of churches in cities peaked around 1932. In 1937, letters were written to the Central Committee of the Communist Party of the Soviet Union to rename Moscow to "Stalindar" or "Stalinodar". Stalin rejected this suggestion. During World War II, the State Defense Committee and the General Staff of the Red Army were located in Moscow. In 1941, 16 divisions of the national volunteers (more than 160,000 people), 25 battalions, and 4 engineering regiments were formed among Muscovites. Between October 1941 and January 1942, the German Army Group Centre was stopped at the outskirts of the city, and then repelled in the Battle of Moscow. Many factories were evacuated, together with much of the government, and from 20 October the city was declared to be under siege.
Sources: en.wikipedia.org
== Presentation == Abdominal discomfort begins two to six hours after eating unripe ackee fruit, followed by sudden onset vomiting. In severe cases, profound dehydration, seizures, coma, and death may ensue. Children and those who are malnourished are more susceptible to the disease. Clinically the diagnosis is that of a toxic encephalopathy.
== Treatment == Full recovery from both complete and partial tears typically takes 12 weeks or more. However, activities may gradually resume after 6–8 weeks when the plantar fascia will be mostly recovered. Surgery is typically a last resort. At home, it might be advisable to follow the RICE method to reduce inflammation and ease pain.
However, if the exon is present, the exon is sequenced to identify the mutation, therefore causing exclusion of the exon from cDNA. If no cDNA is created by RT-PCR, then multiplex PCR is performed on the notion that most or all of the gene is obliterated.
42 BC to at least early 5th century, Mark Antony (emblem: capricorn) Legio V Macedonica (Macedonian): 43 BC – AD 637, Octavian (emblem: bull) Legio V Alaudae (Larks): 52 BC – AD 70 or 86 (destroyed either during the Batavian rebellion or by the Dacians in first Battle of Tapae), Julius Caesar (emblem: elephant) Legio VI Ferrata (Ironclad): 52 BC – after AD 250, Julius Caesar (emblem: bull, she-wolf and Romulus and Remus); twin legion of Legio VI Victrix Legio VI Victrix (Victorious): 41 BC – after AD 402, Octavian (emblem: bull) Legio VII Claudia Pia Fidelis (loyal and faithful to Claudius): before 58 BC – 44 BC, Julius Caesar; disbanded and re-formed by Octavian Legio VIII Augusta: 59 BC – 46 BC, Julius Caesar, originally named Gallica, disbanded and re-enlisted by Octavian as Legio VIII Augusta, 44 BC – AD 420 Legio IX Hispana (Hispanian): before 58 BC – AD 120-161 Legio X Equestris (Equestrian): before 58 BC – 45 BC, Julius Caesar's personal legion, later renamed as Legio X Gemina Legio X Fretensis (of the sea strait): levied by Octavian in 41/40 BC, recorded to have existed at least until the 410s Legio XI Claudia: 58 BC – 45 BC, Julius Caesar (emblem: Neptune), disbanded, reconstituted by Octavian Legio XII Fulminata (Thunderbolt): 57 BC – AD 45, Julius Caesar, first reconstituted by Lepidus in 43 BC, named by Mark Antony as Legio XII Antiqua (Ancient) Legio XIII Gemina (Twin): 57 BC – 45 BC: Julius Caesar, later (41 BC) reconstituted by Octavian. The legion that crossed the Rubicon with Caesar on his assault on Rome.
== History == Historically, potassium alum was used extensively in the wool industry from Classical antiquity, during the Middle Ages, and well into 19th century as a mordant or dye fixative in the process of turning wool into dyed bolts of cloth.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.